EE03090B1 - Kinoliin-3-karboksamiidühendite kasutamine kompositsiooni valmistamiseks I tüüpi suhkurtõve raviks - Google Patents
Kinoliin-3-karboksamiidühendite kasutamine kompositsiooni valmistamiseks I tüüpi suhkurtõve raviksInfo
- Publication number
- EE03090B1 EE03090B1 EE9400269A EE9400269A EE03090B1 EE 03090 B1 EE03090 B1 EE 03090B1 EE 9400269 A EE9400269 A EE 9400269A EE 9400269 A EE9400269 A EE 9400269A EE 03090 B1 EE03090 B1 EE 03090B1
- Authority
- EE
- Estonia
- Prior art keywords
- quinoline
- diabetes
- preparation
- treatment
- composition
- Prior art date
Links
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title 1
- BLTDCIWCFCUQCB-UHFFFAOYSA-N quinoline-3-carboxamide Chemical class C1=CC=CC2=CC(C(=O)N)=CN=C21 BLTDCIWCFCUQCB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9201076A SE9201076L (sv) | 1992-04-06 | 1992-04-06 | Användningen av gamla läkemedel för behandling av diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE03090B1 true EE03090B1 (et) | 1998-06-15 |
Family
ID=20385863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9400269A EE03090B1 (et) | 1992-04-06 | 1994-11-17 | Kinoliin-3-karboksamiidühendite kasutamine kompositsiooni valmistamiseks I tüüpi suhkurtõve raviks |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5594005A (et) |
| EP (1) | EP0634931A1 (et) |
| JP (1) | JPH07506568A (et) |
| KR (1) | KR950700738A (et) |
| CN (1) | CN1081671A (et) |
| AU (1) | AU667362B2 (et) |
| CA (1) | CA2131831C (et) |
| EE (1) | EE03090B1 (et) |
| HU (1) | HUT69710A (et) |
| IL (1) | IL105285A0 (et) |
| NO (1) | NO943723L (et) |
| NZ (1) | NZ251494A (et) |
| PH (1) | PH30820A (et) |
| SE (1) | SE9201076L (et) |
| WO (1) | WO1993019756A1 (et) |
| ZA (1) | ZA932450B (et) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6133285A (en) * | 1998-07-15 | 2000-10-17 | Active Biotech Ab | Quinoline derivatives |
| SE9802549D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
| SE9802550D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
| FR2827600A1 (fr) * | 2001-07-20 | 2003-01-24 | Lipha | Derives acides de quinolone et leurs applications en therapeutique |
| US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US8653143B2 (en) * | 2008-10-09 | 2014-02-18 | Newtree Co., Ltd. | Use of panduratin derivative or Boesenbergia pandurata extract |
| KR20130065728A (ko) * | 2010-10-14 | 2013-06-19 | 임뮤나르 에이비 | Ahr 활성화제로서의 1,2-디히드로-4-히드록시-2-옥소-퀴놀린-3-카르복사닐리드 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1034124A (en) * | 1973-05-11 | 1978-07-04 | Ciba-Geigy Ag | Process for the manufacture of new quinolines |
| FR2340735A1 (fr) * | 1976-02-11 | 1977-09-09 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
| IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
| DE3134780A1 (de) * | 1981-09-02 | 1983-03-10 | Hoechst Ag, 6000 Frankfurt | "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung" |
| US5310913A (en) * | 1989-06-09 | 1994-05-10 | Kabi Pharmacia Aktiebolag | Derivatives of quinoline-3-carboxanilide |
| SE9000624D0 (sv) * | 1990-02-22 | 1990-02-22 | Pharmacia Ab | New use |
| SE9001111D0 (sv) * | 1990-03-27 | 1990-03-27 | Pharmacia Ab | Supportive use |
-
1992
- 1992-04-06 SE SE9201076A patent/SE9201076L/xx not_active Application Discontinuation
-
1993
- 1993-03-31 AU AU39131/93A patent/AU667362B2/en not_active Ceased
- 1993-03-31 HU HU9402854A patent/HUT69710A/hu unknown
- 1993-03-31 WO PCT/SE1993/000272 patent/WO1993019756A1/en not_active Ceased
- 1993-03-31 JP JP5517372A patent/JPH07506568A/ja active Pending
- 1993-03-31 CA CA002131831A patent/CA2131831C/en not_active Expired - Fee Related
- 1993-03-31 EP EP93908245A patent/EP0634931A1/en not_active Withdrawn
- 1993-03-31 US US08/313,302 patent/US5594005A/en not_active Expired - Fee Related
- 1993-03-31 NZ NZ251494A patent/NZ251494A/en unknown
- 1993-04-02 PH PH45991A patent/PH30820A/en unknown
- 1993-04-02 IL IL105285A patent/IL105285A0/xx unknown
- 1993-04-05 ZA ZA932450A patent/ZA932450B/xx unknown
- 1993-04-05 CN CN93105195A patent/CN1081671A/zh active Pending
-
1994
- 1994-10-05 NO NO943723A patent/NO943723L/no unknown
- 1994-10-06 KR KR1019940703534A patent/KR950700738A/ko not_active Ceased
- 1994-11-17 EE EE9400269A patent/EE03090B1/et unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO943723D0 (no) | 1994-10-05 |
| ZA932450B (en) | 1993-10-20 |
| CA2131831A1 (en) | 1993-10-14 |
| AU3913193A (en) | 1993-11-08 |
| HUT69710A (en) | 1995-09-28 |
| NO943723L (no) | 1994-10-05 |
| EP0634931A1 (en) | 1995-01-25 |
| KR950700738A (ko) | 1995-02-20 |
| AU667362B2 (en) | 1996-03-21 |
| JPH07506568A (ja) | 1995-07-20 |
| PH30820A (en) | 1997-10-17 |
| IL105285A0 (en) | 1993-08-18 |
| SE9201076D0 (sv) | 1992-04-06 |
| WO1993019756A1 (en) | 1993-10-14 |
| NZ251494A (en) | 1997-07-27 |
| US5594005A (en) | 1997-01-14 |
| SE9201076L (sv) | 1993-10-07 |
| HU9402854D0 (en) | 1995-01-30 |
| CA2131831C (en) | 1999-03-09 |
| CN1081671A (zh) | 1994-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI951413L (fi) | Pintakäsittelykoostumus | |
| FI930747A7 (fi) | Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö | |
| FI903215A7 (fi) | Heteroaryyliamino- ja heteroaryylioksipyridiiniamiineja ja niihin liittyviä yhdisteitä, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä | |
| FI945281A7 (fi) | Heterosykliset yhdisteet, niiden valmistus ja käyttö | |
| FI931901A7 (fi) | Atsoliyhdisteet, niiden valmistus ja käyttö | |
| FI925661L (fi) | Injicerbar farmaceutisk komposition | |
| FI914419A7 (fi) | Uusia insuliiniyhdisteitä | |
| FI910310A7 (fi) | Asesulfaami-K:ta sisältävä koostumus | |
| FI935887A7 (fi) | Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö | |
| FI930656A0 (fi) | Komposition foer nasal behandling | |
| DK90089A (da) | Hudbehandlingspraeparat | |
| FI930746A7 (fi) | Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö | |
| FI943313A7 (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
| FI942963A7 (fi) | Imidatsokinatsoliiniyhdisteitä ja niiden valmistus ja käyttö | |
| EE9400257A (et) | Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks | |
| FI954229L (fi) | Heterosykliset yhdisteet, niiden käyttö ja valmistus | |
| UA26064A1 (uk) | Фармацевтичhа композиція | |
| FI946057A7 (fi) | Paikalliseen käyttöön tarkoitettu valmiste | |
| DE69323607D1 (de) | Flüssige korrekturzusammensetzung | |
| FI935654A7 (fi) | Kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö | |
| FI911644A7 (fi) | Terapeuttinen yhdiste ja koostumus | |
| KR930702465A (ko) | 카르복시에스테르 복합체를 함유하는 액체 조성물 | |
| KR950700738A (ko) | 당뇨병 치료를 위한 퀴놀린-3-카르복시아미드 화합물의 용도(the use of quinoline-3-carboxamide compounds for treatment of diabetes) | |
| FI915979A7 (fi) | Fenyylialkyyliaminoalkyyliyhdisteet sekä menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet | |
| FI914525A7 (fi) | Yhdiste, käyttö ja valmistus |